It is believed about 200 roles will be cut at the facility in Barnard Castle, County Durham, in October 2025. The team ...

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

seeking to invalidate three GSK patients covering its RSVPreF3 shot, according to a report on the Law360.com website. GSK's vaccine has just hit the mark in a phase 3 trial, and the company is ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data ... 2 In both groups, the most frequently reported adverse events were pain at the injection site, fatigue, and myalgia. 2 The duration of ...

It has now confirmed Sandoz has decided not to renew its contract. The move comes as GSK confirmed it was shutting its site at Ulverston, Cumbria, which has also been producing the antibiotic for ...

GSK PLC GSK shares slipped 1.84% to £15.75 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.72. Supported ...